East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Checkpoint Therapeutics Inc.'s planned $355 million sale to Sun Pharmaceuticals Inc. will likely siphon value from public ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Almost all the patients with depression who received Gilgamesh Pharmaceuticals’ psychedelic drug candidate went into ...

Danish privately-held drugmaker MC2 Therapeutics today announced the appointment of Trine Ahlgreen as chief executive (CEO).

The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...

Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.